ERBB2 and triple-negative breast carcinoma: These aggressive tumors lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are thus referred to as triple-negative breast cancer (TNBC) [2].